This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignees: Kagoshima University, Nagasaki University, Tokyo Metropolitan Institute of Medical Science. Active years: 2025.
Company Filing History:
1 out of 80 
1 out of 60 
1 out of 56 Years Active: 2025
Title: Fumihiko Yasui: Innovator in Dengue Virus Vaccine Development
Introduction
Fumihiko Yasui is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of medical science, particularly in the development of vaccines. His innovative work has the potential to impact public health positively.
Latest Patents
Fumihiko Yasui holds a patent for a dengue virus vaccine. The invention provides a recombinant Vaccinia virus that can be utilized as a therapeutic or prophylactic agent in clinical settings. This recombinant Vaccinia virus is characterized by including all or part of a cDNA that encodes a non-structural protein from a dengue virus, along with an expression promoter. This advancement represents a crucial step in combating dengue fever.
Career Highlights
Throughout his career, Fumihiko Yasui has worked with esteemed institutions such as the Tokyo Metropolitan Institute of Medical Science and Kagoshima University. His research has focused on developing innovative solutions to pressing health issues, particularly in the realm of infectious diseases.
Collaborations
Fumihiko Yasui has collaborated with notable colleagues, including Michinori Kohara and Daisuke Yamane. These partnerships have fostered a collaborative environment that enhances the research and development of effective medical solutions.
Conclusion
Fumihiko Yasui's work in developing a dengue virus vaccine showcases his dedication to advancing medical science. His innovative contributions are vital in the ongoing fight against infectious diseases, and his collaborations further strengthen the impact of his research.